152 related articles for article (PubMed ID: 37673108)
1. Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Ettinger DS; Wood DE; Stevenson J; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; DeCamp M; Dilling TJ; Dowell J; Durm GA; Gettinger S; Grotz TE; Gubens MA; Hegde A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Mullikin TC; Ng T; Otterson GA; Patel SP; Patil T; Polanco PM; Riely GJ; Riess J; Shapiro TA; Singh AP; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory KM; Hughes M
J Natl Compr Canc Netw; 2023 Sep; 21(9):961-979. PubMed ID: 37673108
[TBL] [Abstract][Full Text] [Related]
2. Mesothelioma: Pleural, Version 1.2024.
Stevenson J; Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; DeCamp M; Desai A; Dilling TJ; Dowell J; Durm GA; Garassino MC; Gettinger S; Grotz TE; Gubens MA; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Mullikin TC; Ng T; Otterson GA; Owen D; Patel SP; Patil T; Polanco PM; Riely GJ; Riess J; Shapiro TA; Singh AP; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory K; Hang L
J Natl Compr Canc Netw; 2024 Mar; 22(2):72-81. PubMed ID: 38503043
[TBL] [Abstract][Full Text] [Related]
3. Malignant pleural mesothelioma: an update.
Hajj GNM; Cavarson CH; Pinto CAL; Venturi G; Navarro JR; Lima VCC
J Bras Pneumol; 2021; 47(6):e20210129. PubMed ID: 34909922
[TBL] [Abstract][Full Text] [Related]
4. NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Dilling T; Dobelbower M; Govindan R; Hennon M; Horn L; Jahan TM; Komaki R; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Sharma N; Swanson SJ; Stevenson J; Tauer K; Yang SC; Gregory K; Hughes M
J Natl Compr Canc Netw; 2016 Jul; 14(7):825-36. PubMed ID: 27407123
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses.
Kawai T; Tominaga S; Hiroi S; Ogata S; Nakanishi K; Kawahara K; Sonobe H; Hiroshima K
J Clin Pathol; 2016 Aug; 69(8):706-12. PubMed ID: 26729015
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal mesothelioma: a review.
Bridda A; Padoan I; Mencarelli R; Frego M
MedGenMed; 2007 May; 9(2):32. PubMed ID: 17955087
[TBL] [Abstract][Full Text] [Related]
7. Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
Churg A; Attanoos R; Borczuk AC; Chirieac LR; Galateau-Sallé F; Gibbs A; Henderson D; Roggli V; Rusch V; Judge MJ; Srigley JR
Arch Pathol Lab Med; 2016 Oct; 140(10):1104-10. PubMed ID: 27031777
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.
Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA
Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
[TBL] [Abstract][Full Text] [Related]
9. Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.
Lagana SM; Taub RN; Borczuk AC
Arch Pathol Lab Med; 2012 Jul; 136(7):804-9. PubMed ID: 22742553
[TBL] [Abstract][Full Text] [Related]
10. Nonpleural mesotheliomas: mesothelioma of the peritoneum, tunica vaginalis, and pericardium.
Hassan R; Alexander R
Hematol Oncol Clin North Am; 2005 Dec; 19(6):1067-87, vi. PubMed ID: 16325124
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Malignant Peritoneal Mesothelioma.
Levý M; Boublíková L; Büchler T; Šimša J
Klin Onkol; 2019; 32(5):333-337. PubMed ID: 31610664
[TBL] [Abstract][Full Text] [Related]
12. [Clinical Pathological Diagnosis, and Treatment for Pleural Mesothelioma].
Kishimoto T; Fujimoto N; Nishi H
Gan To Kagaku Ryoho; 2016 May; 43(5):513-7. PubMed ID: 27210080
[TBL] [Abstract][Full Text] [Related]
13. Traditional Treatment Approaches and Role of Immunotherapy in Lung Malignancy and Mesothelioma.
Tamanna MT; Egbune C
Cancer Treat Res; 2023; 185():79-89. PubMed ID: 37306905
[TBL] [Abstract][Full Text] [Related]
14. Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.
Ascoli V; Minelli G; Cozzi I; Romeo E; Carnovale Scalzo C; Ancona L; Forastiere F
Pathol Res Pract; 2016 Oct; 212(10):886-892. PubMed ID: 27485167
[TBL] [Abstract][Full Text] [Related]
15. ['Malignant peritoneal mesothelioma': a condition difficult to diagnose].
van der Valk FM; van Leeuwen J
Ned Tijdschr Geneeskd; 2012; 156(15):A4269. PubMed ID: 22495008
[TBL] [Abstract][Full Text] [Related]
16. Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR).
Klebe S; Judge M; Brcic L; Dacic S; Galateau-Salle F; Nicholson AG; Roggli V; Nowak AK; Cooper WA
Histopathology; 2024 Mar; 84(4):633-645. PubMed ID: 38044849
[TBL] [Abstract][Full Text] [Related]
17. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy.
Lee M; Alexander HR; Burke A
Pathology; 2013 Aug; 45(5):464-73. PubMed ID: 23846294
[TBL] [Abstract][Full Text] [Related]
18. Incidental finding of multiple well-differentiated papillary mesotheliomas in peritoneum.
Jakobsen M; Engvad B; Jensen T; Marcussen N
APMIS; 2016 Apr; 124(4):333-4. PubMed ID: 26766140
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of diffuse malignant peritoneal mesothelioma.
Hung YP; Dong F; Torre M; Crum CP; Bueno R; Chirieac LR
Mod Pathol; 2020 Nov; 33(11):2269-2279. PubMed ID: 32504035
[TBL] [Abstract][Full Text] [Related]
20. Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation.
Shi M; Fraire AE; Chu P; Cornejo K; Woda BA; Dresser K; Rock KL; Jiang Z
Am J Surg Pathol; 2011 Jun; 35(6):878-82. PubMed ID: 21566519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
